Overexpression of FTO reduced plasma total cholesterol levels and oxLDL deposition in macrophages, and increased cholesterol efflux from macrophages/foam cells by inhibiting the expression of PPARγ and CD36, alleviating lipid metabolism disorder. The gene discussed is FTO; the disease is Disorder of lipid metabolism.